| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |